Salarius Pharmaceuticals, LLC logo

Salarius Pharmaceuticals, LLC

Salarius Pharmaceuticals is an emerging biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. The lead compound Seclidemstat represents a potential paradigm shift in the treatment of cancer and we are initially targeting Ewing sarcoma, a devastating pediatric, adolescent and young adult bone cancer where no targeted therapies are currently available.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://salariuspharma.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
2450 Holcombe Blvd., Suite J-608, TX, 77021
Houston
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/salarius-pharmaceuticals” connections=”true” suffix=””]